Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence-Reference-Cited by-同舟云学术

Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence

Published:2014-03 Issue:3 Volume:45 Page:504-512
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Ortiz-Martínez Fernando,Perez-Balaguer Ariadna,Ciprián Daniel,Andrés Leire,Ponce José,Adrover Encarna,Sánchez-Payá José,Aranda Francisco I.,Lerma Enrique,Peiró Gloria

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference34 articles.

1. Cancer treatment and survivorship statistics, 2012;Siegel;CA Cancer J Clin,2012

2. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc Natl Acad Sci U S A,2003

3. The role of osteopontin in tumor progression and metastasis in breast cancer;Rodrigues;Cancer Epidemiol Biomarkers Prev,2007

4. Osteopontin induces multiple changes in gene expression that reflect the six “hallmarks of cancer” in a model of breast cancer progression;Cook;Mol Carcinog,2005

5. Interactions between breast cancer cells and bone marrow derived cells in vitro define a role for osteopontin in affecting breast cancer cell migration;Koro;Breast Cancer Res Treat,2011

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EXPRESSION OF SPP1 AND SPARC GENES IN TUMOR TISSUE OF PATIENTS WITH BREAST CANCER;Experimental Oncology;2024-05-31

2. Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway;Journal of Cancer Research and Clinical Oncology;2024-03-25

3. Meta-analysis of Osteopontin splice variants in cancer;BMC Cancer;2023-04-24

4. Altered Adipokine Expression in Tumor Microenvironment Promotes Development of Triple Negative Breast Cancer;Cancers;2022-08-26

5. Osteopontin and its downstream carcinogenic molecules: regulatory mechanisms and prognostic value in cancer progression;Neoplasma;2022